Home Markets Pfizer, BioNTech Reach Deal With COVAX For Up To 40 Mln Doses...

Pfizer, BioNTech Reach Deal With COVAX For Up To 40 Mln Doses Of COVID-19 Vaccine

5
investorsdiurnal business news magazine

This post was originally published on this site

(RTTNews) – Pfizer Inc. (PFE) and BioNTech announced an advance purchase agreement with COVAX for up to 40 million doses of the Pfizer-BioNTech COVID-19 Vaccine. Financial terms of the agreement were not disclosed. The doses will be delivered throughout 2021.

The companies expect to deliver the first doses in the first quarter of 2021.